YOLFTbeta
41

Adimmune Corp

4142 · TW · Healthcare / Biotechnology

16.80TWD+0.10 (+0.60%)

Price History

Full chart

Market Stats

Previous Close16.70
Open16.85
Day Range16.75 – 17.15
52-Week Range16.40 – 22.50
Volume724.64K
Market Cap7.59B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.34
Dividend Yield0.00%
Beta0.27
50-Day Avg17.52
200-Day Avg18.00

About

Adimmune Corporation engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally. The company offers AdimFlu-S, a quadrivalent influenza vaccine; suspensions for injection influenza vaccines; and tetanus toxoid alum precipitated product for the prevention of tetanus after injury. It also develops AdimrSC-2f, a subunit protein-based vaccine for the prevention of COVID-19; H5N1 vaccine; and cell culture-derived Japanese encephalitis vaccine. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001. Adimmune Corporation was incorporated in 1965 and is headquartered in Taichung, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Chi-Hsien Chan
  • Employees0
  • HeadquartersNo. 3, Tanxing Road, Taichung, Taiwan, 427003, Taiwan
  • Websitehttps://www.adimmune.com.tw

Leadership

  • Mr. Chi-Hsien ChanCEO & Chairman
  • Mr. Chin-Chuan ChangCOO and VP of R&D
  • Mr. Chin-I ChiuVice President of Quality Assurance Department
  • Jade HsuChief Financial Officer
  • Ms. Li-Ya TangDirector of Administration Center
  • Mr. Fei PanChief Legal Officer & General Counsel
  • Zhe Wei ZhangExecutive Vice GM
  • Chih-Hsiang LengHead of R&D Division
  • Yuan Hou YanDeputy Chief Operating Officer
  • Yue Peng HongDeputy Chief Operating Officer

Financials

Income Statement

Currency: TWD2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue223.54M182.34M1.37B834.77M290.36M387.16M414.09M480.51M290.74M606.73M562.74M822.37M1.30B1.87B1.64B2.25B1.79B1.56B1.40B
Growth (%)--18.43%+651.33%-39.06%-65.22%+33.34%+6.96%+16.04%-39.49%+108.69%-7.25%+46.14%+58.04%+43.81%-12.20%+37.21%-20.72%-12.78%-9.99%
Cost of Revenue158.50M163.89M344.78M298.35M519.72M757.53M661.52M685.70M581.14M795.37M823.98M1.12B1.13B1.25B1.18B1.36B1.37B1.11B1.11B
Gross Profit65.05M18.44M1.03B536.43M-229.36M-370.37M-247.43M-205.19M-290.41M-188.64M-261.24M-294.31M167.59M623.06M464.14M891.08M410.94M448.06M288.49M
Gross Margin29.10%10.11%74.83%64.26%-78.99%-95.66%-59.75%-42.70%-99.89%-31.09%-46.42%-35.79%12.89%33.33%28.28%39.58%23.02%28.78%20.58%
Operating Expense97.88M102.93M284.53M315.58M351.75M296.12M399.06M442.41M447.12M403.23M443.98M430.91M466.57M648.88M518.24M792.53M1.13B747.15M648.04M
Operating Income-32.84M-84.49M740.62M220.85M-581.11M-666.49M-646.49M-647.60M-737.52M-591.87M-705.22M-725.21M-298.98M-25.81M-54.09M98.55M-722.75M-299.09M-359.55M
Operating Margin-14.69%-46.34%54.06%26.46%-200.13%-172.15%-156.12%-134.78%-253.67%-97.55%-125.32%-88.19%-23.00%-1.38%-3.30%4.38%-40.49%-19.21%-25.65%
EBITDA-54.96M-74.80M861.38M450.25M-333.31M-366.55M-326.34M-318.99M-400.02M-302.29M-445.84M-372.12M-33.32M1.45B254.89M438.12M-512.43M-84.30M-144.69M
EBITDA Margin-24.58%-41.02%62.88%53.94%-114.79%-94.68%-78.81%-66.39%-137.59%-49.82%-79.23%-45.25%-2.56%77.42%15.53%19.46%-28.71%-5.41%-10.32%
Net Income-34.30M-72.45M588.88M161.31M-471.32M-603.68M-600.45M-614.42M-761.09M-595.35M-760.18M-617.84M-280.68M1.24B43.07M290.98M-639.89M-242.75M-239.89M
Net Income Margin-15.34%-39.73%42.99%19.32%-162.32%-155.92%-145.00%-127.87%-261.78%-98.13%-135.08%-75.13%-21.60%66.41%2.62%12.92%-35.85%-15.59%-17.12%
R&D33.13M30.77M86.00M143.91M194.85M152.16M189.01M238.83M205.48M164.71M222.32M205.91M235.64M337.68M321.28M346.42M296.93M292.05M237.40M
R&D as % of Total Revenue14.82%16.87%6.28%17.24%67.10%39.30%45.64%49.70%70.68%27.15%39.51%25.04%18.13%18.07%19.58%15.39%16.63%18.76%16.94%
Interest Expense557.00K629.00K16.30M12.66M22.28M33.49M43.37M40.64M25.84M33.52M39.28M44.39M41.06M22.16M14.69M22.59M33.43M36.49M31.16M
Interest Expense % of Total Revenue0.25%0.34%1.19%1.52%7.67%8.65%10.47%8.46%8.89%5.53%6.98%5.40%3.16%1.19%0.90%1.00%1.87%2.34%2.22%

Balance Sheet

Currency: TWD2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.14B4.19B5.71B5.42B5.61B5.99B5.49B5.86B5.43B6.78B5.75B5.68B6.57B8.47B8.01B9.15B9.48B8.48B8.19B
Total Liabilities218.90M1.02B1.94B1.35B2.01B2.25B2.25B1.39B1.75B3.69B3.40B3.82B2.74B1.84B1.58B2.60B3.71B2.92B3.14B
Total Equity1.92B3.17B3.77B4.06B3.58B3.74B3.24B4.20B3.44B2.88B2.11B1.64B3.65B6.32B6.15B6.12B5.47B5.23B4.94B
Cash49.82M129.30M1.10B881.52M950.00M1.10B507.05M1.01B942.52M1.67B1.23B627.36M1.05B4.09B2.65B2.86B2.46B2.34B2.19B
Total Debt77.52M870.00M1.48B1.20B1.93B2.12B2.12B1.26B1.60B3.49B3.10B3.56B2.61B1.32B1.32B2.26B3.14B2.60B2.83B
Net Debt27.71M740.70M387.45M321.25M984.46M1.03B1.54B171.09M657.48M1.82B1.79B2.86B1.48B-2.77B-1.33B-594.50M685.13M252.12M644.08M

Cash Flow

Currency: TWD2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow31.26M-135.69M600.42M516.39M-293.77M-409.48M-568.64M-417.35M-373.82M-773.53M6.87M-601.74M-252.72M2.32B-480.52M-291.96M-892.35M668.48M-5.45M
Investing Cash Flow-634.85M-1.40B-727.64M-621.52M-379.72M-399.24M-49.50M-21.64M-11.92M-443.33M-98.48M-497.77M-631.97M382.76M-728.84M-322.07M-366.56M-310.90M-198.98M
Financing Cash Flow472.41M2.11B575.79M-109.44M741.97M955.00M-22.37M941.12M319.09M1.94B-343.80M491.88M1.32B323.88M-222.89M823.19M859.30M-478.80M56.19M
Capital Expenditure265.77M1.33B703.82M626.30M406.15M376.98M63.46M20.40M8.71M19.36M11.35M22.69M55.74M218.30M845.26M419.63M221.46M155.22M236.74M
Free Cash Flow-234.51M-1.47B-103.39M-109.91M-699.93M-786.45M-632.10M-437.75M-382.53M-792.89M-4.47M-624.43M-317.45M2.10B-1.33B-711.59M-1.11B513.26M-242.18M
Dividends Paid-----------214.75M214.75M214.75M214.75M----
FCF to OCF-750.18%1082.23%-17.22%-21.28%238.25%192.06%111.16%104.89%102.33%102.50%-65.07%103.77%125.61%90.60%275.91%243.72%124.82%76.78%4446.97%
Dividend Paid to FCF------------34.39%-67.65%10.21%-16.20%----

Earnings

Report DateJun 30, 2011Sep 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Oct 31, 2012Feb 27, 2013May 29, 2013Aug 13, 2013Nov 27, 2013Mar 31, 2014May 28, 2014Aug 11, 2014Nov 14, 2014Mar 31, 2015May 17, 2015Aug 13, 2015Nov 13, 2015Mar 2, 2016May 13, 2016Aug 15, 2016Nov 2, 2016Mar 31, 2017May 12, 2017Aug 14, 2017Nov 14, 2017Mar 30, 2018May 15, 2018Aug 13, 2018Nov 13, 2018Mar 30, 2019May 15, 2019Aug 13, 2019Nov 12, 2019Feb 26, 2020May 14, 2020Aug 14, 2020Nov 10, 2020Mar 26, 2021May 14, 2021Aug 12, 2021Nov 11, 2021Mar 30, 2022May 10, 2022Aug 15, 2022Nov 14, 2022Mar 14, 2023May 15, 2023Aug 11, 2023Nov 12, 2023Mar 13, 2024Mar 12, 2025May 14, 2025
EPS Estimate------0.54---0.55--0.82--0.31-0.39-0.86-0.56-0.93-0.44--0.53---0.50-0.38-0.40------0.17-0.68-0.170.09-0.04-0.790.370.02-0.38-0.470.250.16-0.440.070.470.27-0.49-0.090.67-0.21-0.65
EPS Actual-1.14-0.59-1.00-0.77-0.85-0.76-0.96-0.87-0.59-0.56-0.98-0.780.09-1.23-1.14-0.61-0.39-0.81-1.36-0.63-0.43-0.52-0.91-0.79-0.63-0.45-1.22-0.72-0.31-0.02-1.39-0.83-0.620.31-0.06-0.05-0.350.383.03-0.58-0.380.370.69-0.550.110.980.14-0.59-0.570.62-0.98-0.12-0.53
Surprise------40.74%---7.27%--19.51%-129.03%-215.38%-32.56%-8.93%58.06%-84.09%--18.87%---82.00%-107.89%-57.50%------717.65%-22.06%-264.71%244.44%--225.00%55.70%2.70%15050.00%-52.63%19.15%48.00%331.25%-25.00%57.14%108.51%-48.15%-20.41%-533.33%-7.46%--157.14%18.46%
Timing-----After-hours--After-hours-After-hours-After-hours-Pre-marketAfter-hoursPre-marketPre-market-After-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hours-After-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-market-Pre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hours

Key Statistics & Ratios

Market Cap7.59B
Enterprise Value8.73B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales5.54
Price / Book1.63
EPS-0.34
Book Value10.97
Revenue (TTM)1.37B
Gross Profit (TTM)316.48M
EBITDA-84.88M
Profit Margin-10.48%
Operating Margin-258.72%
Return on Equity-4.40%
Return on Assets-2.00%
Shares Outstanding421.51M
Shares Float313.00M
Beta0.27
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20211×
0.50Sep 14, 2021

Stock Splits

  • Apr 18, 20191323:1256